| Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with … BL McClune, DJ Weisdorf, TL Pedersen, G Tunes da Silva, MS Tallman, ... Journal of Clinical Oncology 28 (11), 1878-1887, 2010 | 567 | 2010 |
| Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity V Mathews, B George, KM Lakshmi, A Viswabandya, A Bajel, ... Blood 107 (7), 2627-2632, 2006 | 429 | 2006 |
| Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: long-term follow-up data V Mathews, B George, E Chendamarai, KM Lakshmi, S Desire, ... Journal of Clinical Oncology 28 (24), 3866-3871, 2010 | 313 | 2010 |
| Pre‐transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era … B George, N Pati, N Gilroy, M Ratnamohan, G Huang, I Kerridge, ... Transplant infectious disease 12 (4), 322-329, 2010 | 223 | 2010 |
| The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome–negative acute … DI Marks, T Wang, WS Pérez, JH Antin, E Copelan, RP Gale, B George, ... Blood, The Journal of the American Society of Hematology 116 (3), 366-374, 2010 | 221 | 2010 |
| Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantation A Srivastava, B Poonkuzhali, RV Shaji, B George, V Mathews, M Chandy, ... Blood 104 (5), 1574-1577, 2004 | 195 | 2004 |
| Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia SJ Lee, M Kukreja, T Wang, SA Giralt, J Szer, M Arora, AE Woolfrey, ... Blood, The Journal of the American Society of Hematology 112 (8), 3500-3507, 2008 | 179 | 2008 |
| Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia AR Tramontana, B George, AC Hurt, JS Doyle, K Langan, AB Reid, ... Emerging infectious diseases 16 (7), 1068, 2010 | 141 | 2010 |
| Acute myeloid leukaemia: challenges and real world data from India C Philip, B George, A Ganapule, A Korula, P Jain, AA Alex, KM Lakshmi, ... British journal of haematology 170 (1), 110-117, 2015 | 138 | 2015 |
| Molecular Mechanisms of Colistin Resistance in Klebsiella pneumoniae Causing Bacteremia from India—A First Report AK Pragasam, C Shankar, B Veeraraghavan, I Biswas, LEB Nabarro, ... Frontiers in microbiology 7, 2135, 2017 | 128 | 2017 |
| Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell … R Thirugnanam, B George, E Chendamarai, KM Lakshmi, ... Biology of Blood and Marrow Transplantation 15 (11), 1479-1484, 2009 | 120 | 2009 |
| Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis HJ Khoury, M Kukreja, JM Goldman, T Wang, J Halter, M Arora, V Gupta, ... Bone marrow transplantation 47 (6), 810-816, 2012 | 119 | 2012 |
| Improved clinical outcomes of high risk β thalassemia major patients undergoing a HLA matched related allogeneic stem cell transplant with a treosulfan based conditioning … V Mathews, B George, A Viswabandya, A Abraham, R Ahmed, ... PloS one 8 (4), e61637, 2013 | 100 | 2013 |
| The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia M Yeshurun, D Weisdorf, JM Rowe, MS Tallman, MJ Zhang, HL Wang, ... Blood advances 3 (4), 670-680, 2019 | 99 | 2019 |
| Treatment of children with newly diagnosed acute promyelocytic leukemia with arsenic trioxide: a single center experience B George, V Mathews, B Poonkuzhali, RV Shaji, A Srivastava, M Chandy Leukemia 18 (10), 1587-1590, 2004 | 97 | 2004 |
| Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell … B George, V Mathews, A Viswabandya, ML Kavitha, A Srivastava, ... Bone marrow transplantation 40 (1), 13-18, 2007 | 92 | 2007 |
| Infections among allogeneic bone marrow transplant recipients in India B George, V Mathews, A Srivastava, M Chandy Bone Marrow Transplantation 33 (3), 311-315, 2004 | 92 | 2004 |
| Long-term outcome following splenectomy for chronic and persistent immune thrombocytopenia (ITP) in adults and children: splenectomy in ITP R Ahmed, AJ Devasia, A Viswabandya, KM Lakshmi, A Abraham, S Karl, ... Annals of hematology 95, 1429-1434, 2016 | 90 | 2016 |
| Infection rates among acute leukemia patients receiving alternative donor hematopoietic cell transplantation K Ballen, KW Ahn, M Chen, H Abdel-Azim, I Ahmed, M Aljurf, J Antin, ... Biology of blood and marrow transplantation 22 (9), 1636-1645, 2016 | 89 | 2016 |
| Comparison of outcomes after transplantation of G-CSF–stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients … R Chu, R Brazauskas, F Kan, A Bashey, C Bredeson, B Camitta, ... Biology of Blood and Marrow Transplantation 17 (7), 1018-1024, 2011 | 89 | 2011 |
